Katy Rezvani, M.D., Ph.D. is a Professor of Medicine, Director of Translational Research, Medical Director of the MD Anderson GMP and Cell Therapy Laboratory and Chief, Section of Cellular Therapy, Department of Stem Cell Transplant and Cellular Therapy at MD Anderson Cancer Center. Dr. Rezvani leads the NK cell immunotherapy program at MD Anderson and has translated multiple innovative immunotherapy strategies from bench to bedside.